Plasma genistein and risk of prostate cancer in Chinese population

International Urology and Nephrology

Volumn 47, Issue 6, 2015, Pages 965-970

  Wu, Yishuo ^a,b   Zhang, Limin ^a,b   Na, Rong ^a,b   Xu, Jianfeng ^a,b   Xiong, Zuquan ^a,b   Zhang, Ning ^a,b   Dai, Wanjun ^b   Jiang, Haowen ^a,b   Ding, Qiang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cancer; China; Genistein; Plasma; Prostate

Indexed keywords

GENISTEIN;

AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHINA; CHINESE; DISEASE ASSOCIATION; FAMILY HISTORY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE BIOPSY; PROSTATE CANCER; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; BIOPSY; BLOOD; PATHOLOGY; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

AGED; BIOPSY; CHINA; GENISTEIN; HUMANS; MALE; PROSTATIC NEOPLASMS; RISK ASSESSMENT;

EID: 84929954534     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-015-0981-5     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90
2. Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
3. Howlader NNA, Krapcho M, Garshell J et al (eds.) SEER cancer statistics review, 1975–2010, National Cancer Institute, Bethesda. http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site 2013
4. Lee MM, Gomez SL, Chang JS et al (2003) Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol Biomark Prev 12(7):665–668
5. Dalais FS, Meliala A, Wattanapenpaiboon N et al (2004) Effects of a diet rich in phytoestrogens on prostate-specific antigen and sex hormones in men diagnosed with prostate cancer. Urology 64(3):510–515
6. Yan L, Spitznagel EL (2005) Meta-analysis of soy food and risk of prostate cancer in men. Int J Cancer 117(4):667–669
7. Hwang YW, Kim SY, Jee SH et al (2009) Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer 61(5):598–606
8. Adlercreutz H, Markkanen H (1993) Wata nabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342:1209–1210
9. Wiseman H, Casey K, Bowey EA et al (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80:692–699
10. Heald CL, Ritchie MR, Bolton-Smith C et al (2007) Phyto-oestrogens and risk of prostate cancer in Scottish men. Br J Nutr 98:388–396
11. Fujimoto K, Tanaka M, Hirao Y et al (2008) Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men. Prostate Cancer Prostatic Dis 11:252–257
12. Hu XJ, Song WR, Gao LY et al (2014) Assessment of dietary phytoestrogen intake via plant-derived foods in China. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 31(8):1325–1335
13. de Vere White RW, Tsodikov A, Stapp EC et al (2010) Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer. Nutr Cancer 62(8):1036–1043
14. Kolonel LN, Hankin JH, Whittemore AS et al (2000) Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomark Prev 9(8):795–804
15. Ozasa K, Nakao M, Watanabe Y et al (2004) Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men. Cancer Sci 95(1):65–71
16. Yan L, Spitznagel EL (2009) Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr 89(4):1155–1163
17. Akaza H, Miyanaga N, Takashima N et al (2002) Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration. Jpn J Clin Oncol 32(8):296–300
18. Ward H, Chapelais G, Kuhnle GG et al (2008) Lack of prospective associations between plasma and urinary phytoestrogens and risk of prostate or colorectal cancer in the European Prospective into Cancer-Norfolk study. Cancer Epidemiol Biomark Prev 17(10):2891–2894
19. Huang X, Chen S, Xu L et al (2005) Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res 65(8):3470–3478
20. Xu L, Ding Y, Catalona WJ et al (2009) MEK4 function, genistein treatment, and invasion of human prostate cancer cells. J Natl Cancer Inst 101:1141–1155
21. Craft CS, Xu L, Romero D et al (2008) Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells. Mol Pharmacol 73(1):235–242
22. Li Y, Sarkar FH (2002) Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8(7):2369–2377
23. Chiyomaru T, Yamamura S, Zaman MS et al (2012) Genistein suppresses prostate cancer growth through inhibition of oncogenic microRNA-151. PLoS One 7(8):e43812
24. Chiyomaru T, Yamamura S, Fukuhara S et al (2013) Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer. PLoS One 8(3):e58929
25. Mentor-Marcel R, Lamartiniere CA, Eltoum IE et al (2001) Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP). Cancer Res 61(18):6777–6782
26. Wang J, Eltoum IE, Lamartiniere CA (2007) Genistein chemoprevention of prostate cancer in TRAMP mice. J Carcinog 6:3
27. Lakshman M, Xu L, Ananthanarayanan V et al (2008) Dietary genistein inhibits metastasis of human prostate cancer in mice. Cancer Res 68(6):2024–2032
28. Schröder FH, Roobol MJ, Boevé ER et al (2005) Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol 48(6):922–930
29. Ornish D, Weidner G, Fair WR et al (2005) Intensive lifestyle changes may affect the progression of prostate cancer. J Urol 174(3):1065–1069